OmniAb, Inc.
OABIW- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- SEC CIK
- 0001846253
No open-market purchases or sales by OmniAb, Inc. insiders were filed in the last 90 days; 13 institutions reported holding it in 13F filings for Q2 2026, worth $238.9K in total; no superinvestor holds it.
Other share classesOABI
Q3 2024 vs. Q2 2024
How the institutions holding OmniAb, Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Q3 2024 | Change |
|---|---|---|---|
| Holders | 15 | 15 | 0 |
| Shares | 16.4M | 15.0M | −1.40M (−8.5%) |
| Value | $7.38M | $5.48M | −$1.90M (−25.8%) |
New holders (3)
Institutions that held OmniAb, Inc. at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Hudson Bay Capital Management LP | 253,365 | $91.2K | 0.00% |
| Antara Capital LP | 148,499 | $53.5K | 0.28% |
| Saba Capital Management, L.P. | 20,000 | $7.17K | 0.00% |
Sold out (3)
Institutions that held OmniAb, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Citadel Advisors LLC | 823,900 | $354.2K |
| LMR Partners LLP | 644,600 | $294.8K |
| Privium Fund Management B.V. | 618,504 | $233.8K |